1. Inicio
  2. Publicaciones
  3. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).

Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).

Fecha de publicación: Fecha Ahead of Print:

Autores de I3PT

Participantes ajenos a I3PT

  • Golda T
  • Biondo S
  • Hernández P
  • Targarona E
  • Borda-Arrizabalaga N
  • Reina A
  • Delgado S
  • Vallribera F
  • Caro A
  • Gallego-Plazas J
  • Pascual M
  • Álvarez-Laso C
  • Guadalajara-Labajo HG

Grupos de Investigación

Abstract

The standard treatment of T2-T3ab,N0,M0 rectal cancers is total mesorectal excision (TME) due to the high recurrence rates recorded with local excision. Initial reports of the combination of pre-operative chemoradiotherapy (CRT) and transanal endoscopic microsurgery (TEM) have shown reductions in local recurrence. The TAU-TEM study aims to demonstrate the non-inferiority of local recurrence and the improvement in morbidity achieved with CRT-TEM compared with TME. Here we describe morbidity rates and pathological outcomes.

Datos de la publicación

ISSN/ISSNe:
0923-7534, 1569-8041

ANNALS OF ONCOLOGY  ELSEVIER

Tipo:
Article
Páginas:
78-90
PubMed:
36220461
Enlace a otro recurso:
www.scopus.com

Citas Recibidas en Web of Science: 40

Citas Recibidas en Scopus: 6

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • local excision and rectal cancer, neoadjuvant treatment and rectal cancer, rectal cancer, total mesorectal excision (TME), transanal endoscopic microsurgery (TEM)

Campos de Estudio

Compartir